Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study. (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/21645515.2015.1111496

PubMed Identifier: 26618243

Publication URI: http://europepmc.org/abstract/MED/26618243

Type: Journal Article/Review

Volume: 12

Parent Publication: Human vaccines & immunotherapeutics

Issue: 2

ISSN: 2164-5515